Market openNon-fractional
Hikma Pharmaceuticals/HIK
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1YMAX
About Hikma Pharmaceuticals
Ticker
HIK
Sector
Healthcare
Trading on
LSE
Industry
Pharmaceuticals
Headquarters
London, United Kingdom
Employees
9,100
Website
www.hikma.com
HIK Metrics
BasicAdvanced
£4.1B
Market cap
27.54
P/E ratio
£0.67
EPS
0.45
Beta
£0.57
Dividend rate
3.08%
Dividend yield
Price and volume
Market cap
£4.1B
Beta
0.45
Dividend rate
£0.57
Financial strength
Current ratio
1.568
Quick ratio
0.805
Long term debt to equity
46.627
Total debt to equity
53.916
Dividend payout ratio (TTM)
72.11%
Interest coverage (TTM)
5.96%
Management effectiveness
Return on assets (TTM)
7.32%
Return on equity (TTM)
8.81%
Valuation
Price to earnings (TTM)
27.54
Price to revenue (TTM)
1.8
Price to book
1.85
Price to tangible book (TTM)
3.71
Price to free cash flow (TTM)
12.8
Dividend yield (TTM)
3.08%
Growth
Revenue change (TTM)
14.22%
Earnings per share change (TTM)
1.67%
3-year revenue growth
7.09%
3-year earnings per share growth
-22.29%
3-year dividend per share growth
12.92%
What the Analysts think about HIK
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Hikma Pharmaceuticals stock.
HIK Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
HIK Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
HIK News
AllArticlesVideos
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and LSEG. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market openNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Hikma Pharmaceuticals stock?
Hikma Pharmaceuticals (HIK) has a market cap of £4.1B as of July 04, 2024.
What is the P/E ratio for Hikma Pharmaceuticals stock?
The price to earnings (P/E) ratio for Hikma Pharmaceuticals (HIK) stock is 27.54 as of July 04, 2024.
Does Hikma Pharmaceuticals stock pay dividends?
Yes, the Hikma Pharmaceuticals (HIK) stock pays dividends to shareholders. As of July 04, 2024, the dividend rate is £0.56748 and the yield is 3.08%. Hikma Pharmaceuticals has a payout ratio of 72.11% on a trailing twelve-month basis.
When is the next Hikma Pharmaceuticals dividend payment date?
The next Hikma Pharmaceuticals (HIK) dividend payment date is unconfirmed.
What is the beta indicator for Hikma Pharmaceuticals?
Hikma Pharmaceuticals (HIK) has a beta rating of 0.45. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Hikma Pharmaceuticals stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.